Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132031) titled 'A study on the loss to follow-up rate and influencing factors of intravitreal injection drugs (anti-VEGF drugs) in the real world' on Sept. 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Eye Hospital, Wenzhou Medical University
Condition:
Age-related macular degeneration
Intervention:
Lost to follow-up group:None
Not continued follow-up group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-20
Target Sample Size: Lost to follow-up group:150;Not continued follow-up group:50;Continuing follow-up group:600;
Countries of Recruitment:...